We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current CYCN market cap is 8.13M. The company's latest EPS is USD -1.9420 and P/E is -1.54.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 608k | 0 | 0 | 0 |
| Operating Income | -10.61M | -7.35M | -7.04M | -4.24M | 3.43M |
| Net Income | -10.5M | -7.22M | -6.95M | -4.18M | 7.57M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 4.51M | 3.97M | 3.94M | 1.63M | 0 |
| Operating Income | -125.04M | -81.27M | -55.2M | -44.37M | -9.65M |
| Net Income | -123.01M | -77.8M | -51.65M | -44.08M | -5.26M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 25.05M | 18.08M | 11.46M | 10.1M | 15.21M |
| Total Liabilities | 8.53M | 7.63M | 7.53M | 4.95M | 2.34M |
| Total Equity | 16.52M | 10.45M | 3.93M | 5.15M | 12.87M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 186.48M | 115.38M | 59.33M | 18.08M | 13.37M |
| Total Liabilities | 88.75M | 55.89M | 11.09M | 7.63M | 2.09M |
| Total Equity | 97.73M | 59.49M | 48.25M | 10.45M | 11.29M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -33.57M | -40.61M | -6.21M | -12.77M | -19.7M |
| Investing | N/A | N/A | N/A | N/A | 10.4M |
| Financing | 17k | 29k | N/A | 5.02M | 5.02M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -102.22M | -72.49M | -36.52M | -40.61M | -21.25M |
| Investing | -6.72M | 18k | 1.46M | N/A | 10.4M |
| Financing | 211.57M | 28.09M | 30.79M | 29k | 5.02M |
| Market Cap | 8.13M |
| Price to Earnings Ratio | -1.54 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 1.07 |
| Price to Book Ratio | 0.72 |
| Dividend Yield | - |
| Shares Outstanding | 2.71M |
| Average Volume (1 week) | 1.22k |
| Average Volume (1 Month) | 2k |
| 52 Week Change | -49.05% |
| 52 Week High | 6.75 |
| 52 Week Low | 1.7501 |
| Spread (Intraday) | 0.15 (5%) |
| Company Name | Cyclerion Therapeutics Inc |
| Address |
155 federal street boston, massachusetts 02110 |
| Website | https://www.cyclerion.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
